|
Status |
Public on Sep 02, 2020 |
Title |
Gene expression profiling of colorectal cancer cell lines after treatment with talazoparib |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
We have performed post-treatment gene expression profiling of cell lines to analyze response mechanisms to PARP inhibition.
|
|
|
Overall design |
Four colorectal cancer cell lines were treated with talazoparib at two different concentrations or DMS for control.
|
|
|
Contributor(s) |
Sveen A, Eilertsen IA, Lothe RA |
Citation(s) |
32799124 |
Submission date |
Nov 12, 2019 |
Last update date |
Sep 02, 2020 |
Contact name |
Anita Sveen |
E-mail(s) |
anita.sveen@rr-research.no
|
Organization name |
Institute for Cancer Research, Oslo University Hospital
|
Department |
Department of Molecular Oncology
|
Street address |
P.O.Box 4953, Nydalen
|
City |
Oslo |
ZIP/Postal code |
NO-0424 |
Country |
Norway |
|
|
Platforms (1) |
GPL17586 |
[HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version] |
|
Samples (12)
|
GSM4158446 |
Cell line LS513 treated with 100nM talazoparib |
GSM4158447 |
Cell line LS513 treated with 1000nM talazoparib |
GSM4158448 |
Cell line LS513 treated with DMSO |
GSM4158449 |
Cell line SKCO1 treated with 100nM talazoparib |
GSM4158450 |
Cell line SKCO1 treated with 1000nM talazoparib |
GSM4158451 |
Cell line SKCO1 treated with DMSO |
GSM4158452 |
Cell line SNU61 treated with 100nM talazoparib |
GSM4158453 |
Cell line SNU61 treated with 1000nM talazoparib |
GSM4158454 |
Cell line SNU61 treated with DMSO |
GSM4158455 |
Cell line SW1222 treated with 100nM talazoparib |
GSM4158456 |
Cell line SW1222 treated with 1000nM talazoparib |
GSM4158457 |
Cell line SW1222 treated with DMSO |
|
Relations |
BioProject |
PRJNA589059 |